The DNMT3A ADD domain is required for efficient de novo DNA methylation and maternal imprinting in mouse oocytes
PLOS Genetics · 01.08.2023 · 19 (8) · e1010855
DOI: 10.1371/journal.pgen.1010855 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Genetics, online erschienen am 01.08.2023. Verfasst von Ryuji Uehara und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Epigenomics and Development, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Histones, DNA Methylation. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Establishment of a proper DNA methylation landscape in mammalian oocytes is important for maternal imprinting and embryonic development. De novo DNA methylation in oocytes is mediated by the DNA methyltransferase DNMT3A, which has an ATRX-DNMT3-DNMT3L (ADD) domain that interacts with histone H3 tail unmethylated at lysine-4 (H3K4me0). The domain normally blocks the methyltransferase domain via intramolecular interaction and binding to histone H3K4me0 releases the autoinhibition. However, H3K4me0 is widespread in chromatin and the role of the ADD-histone interaction has not been studied in vivo . We herein show that amino-acid substitutions in the ADD domain of mouse DNMT3A cause dwarfism. Oocytes derived from homozygous females show mosaic loss of CG methylation and almost complete loss of non-CG methylation. Embryos derived from such oocytes die in mid-to-late gestation, with stochastic and often all-or-none-type CG-methylation loss at imprinting control regions and misexpression of the linked genes. The stochastic loss is a two-step process, with loss occurring in cleavage-stage embryos and regaining occurring after implantation. These results highlight an important role for the ADD domain in efficient, and likely processive, de novo CG methylation and pose a model for stochastic inheritance of epigenetic perturbations in germ cells to the next generation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Epigenomics and Development, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
- Division of Gene Expression Dynamics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
- Advanced Genomics Center, National Institute of Genetics, Mishima, Japan.
- Department of Nutrition Science, Nakamura Gakuen University, Fukuoka, Japan.
- Department of Genome Biology, Graduate School of Medicine, Osaka University, Suita, Japan.
ORCID-Profile: Hiroaki Ohishi, Kenjiro Shirane, Hiroyuki Sasaki
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Uehara, R., Au Yeung, W. K., Toriyama, K., Ohishi, H., Kubo, N., Toh, H., Suetake, I., Shirane, K., & Sasaki, H. (2023). The DNMT3A ADD domain is required for efficient de novo DNA methylation and maternal imprinting in mouse oocytes. PLOS Genetics, 19(8), e1010855. https://doi.org/10.1371/journal.pgen.1010855
Vancouver
Uehara R, Au Yeung WK, Toriyama K, Ohishi H, Kubo N, Toh H, et al. The DNMT3A ADD domain is required for efficient de novo DNA methylation and maternal imprinting in mouse oocytes. PLOS Genetics. 2023;19(8):e1010855. doi:10.1371/journal.pgen.1010855
BibTeX
@article{Uehara2023,
author = {Uehara, Ryuji and Au Yeung, Wan Kin and Toriyama, Keisuke and Ohishi, Hiroaki and Kubo, Naoki and Toh, Hidehiro and Suetake, Isao and Shirane, Kenjiro and Sasaki, Hiroyuki},
title = {The DNMT3A ADD domain is required for efficient de novo DNA methylation and maternal imprinting in mouse oocytes},
journal = {PLOS Genetics},
year = {2023},
volume = {19},
number = {8},
pages = {e1010855},
doi = {10.1371/journal.pgen.1010855}
}
EUVIMED